Laricef 500mg/500mg Injection
Marketer
Larion Life Sciences Pvt Ltd
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Laricef 500mg/500mg Injection
Cefixime and Sulbactam 500mg/500mg Injection is a dual-action antibiotic. This medication combats diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; complete the full course of treatment regardless of symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your physician immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Consult your doctor if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, avoid driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration are vital for optimal recovery. Follow-up laboratory and diagnostic testing may be conducted to monitor treatment efficacy.
Uses of Laricef 500mg/500mg Injection
Managing bacterial infections
Major Benefits of Laricef 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Laricef 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Laricef 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Laricef 500mg/500mg Injection works:
Cefoperazone and Sulbactam 500mg/500mg (Laricef) injection combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Cefoperazone's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Sulbactam counteracts bacterial resistance mechanisms, thus boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Laricef 500mg/500mg Injection and alcohol can lead to adverse reactions including facial flushing, tachycardia, nausea, increased thirst, chest discomfort, and hypotension (a disulfiram-like response).
PregnancySAFE IF PRESCRIBED
The injectable formulation of Laricef, 500mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Use of the injectable formulation of Laricef 500mg/500mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Laricef 500mg/500mg Injection on driving ability is undetermined. Refrain from driving if you encounter symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laricef 500mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laricef 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Laricef 500mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Laricef 500mg/500mg Injection, seek guidance from your physician.
Facts to Know About Laricef 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently